S. B. Hanauer - Concepedia

Author

S. B. Hanauer

Also Known As

David Schwartz, S B Hanauer, S HANAUER, S Hanauer, S. B. HANAUER, S. B. Hanauer, S. Hanauer, S.B. Hanauer, Stephen B. Hanauer

Publications

4.1K

Citations

H-Index

Concepts

All Affiliations

University of Chicago University of California San Diego Mayo Clinic University of Calgary Atlanta Gastroenterology Associates

About

S. B. Hanauer is an author at University of Chicago specializing in medicine, gastroenterology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.8K
2	Health Sciences	1	1	11
3	Public Health	1	1	22
4	Biostatistics	1	1	22
5	Diagnostic Sciences	1	1	11

S. B. Hanauer

Publications

3.4K

Citations

H-Index

Page 1

	Year	Citations
Adalimumab for maintenance treatment of Crohn’s disease: results of the CLASSIC II trial William J. Sandborn, S. B. Hanauer, P. Rutgeerts, Gut	2007	1K
Etanercept for active Crohn's disease: A randomized, double-blind, placebo-controlled trial William J. Sandborn, S. B. Hanauer, Seymour Katz, Gastroenterology Functional Gastrointestinal DisorderGastroenterologyClinical TrialsClinical GastroenterologyUlcerative Colitis	2001	905
Thalidomide therapy for patients with refractory Crohn's disease: An open-label trial Eli D. Ehrenpreis, Sunanda V. Kane, Lawrence B. Cohen, Gastroenterology Open-label TrialThalidomide TherapyGastroenterologyClinical GastroenterologySurgery	1999	330
An engineered human antibody to TNF (CDP571) for active Crohn's disease: A randomized double-blind placebo-controlled trial William J. Sandborn, Brian G. Feagan, S. B. Hanauer, Gastroenterology InflammationMucosal ImmunologyMedicineImmunologyPathology	2001	252
Randomised clinical trial: certolizumab pegol for fistulas in Crohn’s disease - subgroup results from a placebo-controlled study Stefan Schreiber, Ian C. Lawrance, Ole Østergaard Thomsen, Alimentary Pharmacology & Therapeutics	2010	160
Randomised clinical trial: the safety and tolerability of<i>Trichuris suis</i>ova in patients with Crohn's disease William J. Sandborn, David E. Elliott, Joel V. Weinstock, Alimentary Pharmacology & Therapeutics	2013	121
Repifermin (keratinocyte growth factor‐2) for the treatment of active ulcerative colitis: a randomized, double‐blind, placebo‐controlled, dose‐escalation trial William J. Sandborn, Bruce E. Sands, Douglas C. Wolf, Alimentary Pharmacology & Therapeutics	2003	112
Cyclosporin for severe ulcerative colitis: a user's guide. Asher Kornbluth, Daniel H. Present, S Lichtiger, PubMed InflammationGastrointestinal PharmacologyGastroenterologySevere Ulcerative ColitisClinical Gastroenterology	1997	110
Infectious Complications Associated with Hairy Cell Leukemia H M Golomb, S. B. Hanauer The Journal of Infectious Diseases	1981	52
Olsalazine Induced Secretion in Rabbit IIeal Mucosa S. B. Hanauer, Rifat Pamukcu, Eugene B. Chang Scandinavian Journal of Gastroenterology Animal PhysiologyInflammationGastrointestinal Peptide HormoneOlsalazine Induced SecretionMedicine	1988	51

Page 1